References
- Bishoff K. B., Dedrick R. L., Zakarko D. S., Longstreth J. A. Methotrexate pharmacokmetics. Journal of Pharmaceutical Sciences 1971; 60: 1128–1133
- Edgar B., Hoffmann K. J., Lundborg P., Regårdh C. G., Rönn O., Weidolf L. Absorption, distribution and elimination of felodipine in man. Drugs 1985; 29(Suppl. 2)9–15
- Girkin R., Baldock G. A., Chasseaud L. F., Hümpel M., Hawkins D. R., Mayo B. C. The absorption, distribution and excretion of [14C]lormetazepam in dogs, rabbits, rats and rhesus monkeys. Xenobiotica 1980; 10: 401–411
- Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Higuchi S., Shiobara Y. Comparative pharmacokinetics of nicardipine hydrochloride, a new vasodilator, in various species. Xenobiotica 1980; 10: 447–454
- Lutz R. J., Dedrick R. L., Matthews H. B., Eling T. E., Anderson M. W. A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metabolism and Disposition 1977; 5: 386–396
- Midgley I., Chasseaud L. F., Taylar I. W., Walmsley L. M., Fowkes A. G., Darragh A., Lambe R. F., Bonn R. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man. Xenobiotica 1985; 15: 965–977
- Niwa T., Tokuma Y., Noguchi H. The oxidation of nilvadipine to the corresponding pyridine by rat liver microsomes. Xenobiotic Metabolism and Disposition 1986; 1: 304–305
- Ohtsuka M., Ono T., Hiroi J., Esumi K., Kikuchi H., Kumada S. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists. Journal of Cardiovascular Pharmacology 1983; 5: 1074–1082
- Pfeffer M. COMPT, a time-sharing program for nonlinear regression analysis of compartment models of drug distribution. Journal of Pharmacokinetics and Biopharmaceutics 1973; 1: 137–163
- Rush W. R., Alexander O., Hall D. J., Cairncross L., Dow R. J., Graham D. J. G. The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica 1986; 16: 341–349
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987, in press
- Tokuma Y., Fujiwara T., Sekiguchi M., Noguchi H. Determination of nilvadipine in plasma and urine by capillary column gas chromatography with electron capture detection. Journal of Chromatography 1987; 415: 156–162
- Wagner J. G. Fundamentals of Clinical Pharmacokinetics. Drug Intelligence Publications, I'linois 1975; 288
- Wagner J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. Journal of Pharmacokinetics and Biopharmaceutics 1976; 4: 443–467